Advertisement
Review| Volume 97, ISSUE 3, P359-367, September 2012

Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency

      Abstract

      Metformin treatment is a known pharmacological cause of vitamin B12 (Cbl) deficiency with controversial responsible mechanisms. A possible diagnosis of this deficiency is based mainly on the combination of patient's medical history (usually long-term metformin use), clinical examination (possible neuropsychiatric symptoms and signs), laboratory studies which confirm a Cbl deficiency (haematological abnormalities, low serum Cbl levels, elevated serum total homocysteine and methylmalonic acid levels), and exclusion other causes of Cbl deficiency (as pernicious anaemia, food-cobalamin malabsorption syndrome, other drugs, etc.). In our review, recommendations for diagnosis and management of metformin-induced Cbl deficiency (MICD) in diabetic patients based on medical bibliography are presented and discussed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Witters L.A.
        The blooming of the French lilac.
        J Clin Invest. 2001; 108: 1105-1107
        • Bouchoucha M.
        • Uzzan B.
        • Cohen R.
        Metformin and digestive disorders.
        Diabetes Metab. 2011; 37: 90-96
        • Nathan D.M.
        • Buse J.B.
        • Davidson M.B.
        • Ferrannini E.
        • Holman R.R.
        • Sherwin R.
        • et al.
        Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
        Diabetes Care. 2009; 32: 193-203
        • American Diabetes Association
        • et al.
        Standards of medical care in diabetes—2012.
        Diabetes Care. 2012; 35: S11-S63
        • Kirpichnikov D.
        • McFarlane S.I.
        • Sowers J.R.
        Metformin: an update.
        Ann Intern Med. 2002; 137: 25-33
        • Towler M.C.
        • Hardie D.G.
        AMP-activated protein kinase in metabolic control and insulin signaling.
        Circ Res. 2007; 100: 328-341
        • Zhou G.
        • Myers R.
        • Li Y.
        • Chen Y.
        • Shen X.
        • Fenyk-Melody J.
        • et al.
        Role of AMP-activated protein kinase in mechanism of metformin action.
        J Clin Invest. 2001; 108: 1167-1174
        • Bailey C.J.
        Biguanides and NIDDM.
        Diabetes Care. 1992; 15: 755-772
        • Collier C.A.
        • Bruce C.R.
        • Smith A.C.
        • Lopaschuk G.
        • Dyck D.J.
        Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle.
        Am J Physiol Endocrinol Metab. 2006; 291: E182-E189
        • Bailey C.J.
        • Turner R.C.
        Metformin.
        N Engl J Med. 1996; 334: 574-579
        • Cho Y.M.
        • Kieffer T.J.
        New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser.
        Diabetologia. 2011; 54: 219-222
        • Maida A.
        • Lamont B.J.
        • Cao X.
        • Drucker D.J.
        Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor alpha in mice.
        Diabetologia. 2011; 54: 339-349
        • Yasuda N.
        • Inoue T.
        • Nagakura T.
        • Yamazaki K.
        • Kira K.
        • Saeki T.
        • et al.
        Enhanced secretion of glucagon-like peptide 1 by biguanide compounds.
        Biochem Biophys Res Commun. 2002; 298: 779-784
        • Migoya E.M.
        • Bergeron R.
        • Miller J.L.
        • Snyder R.N.
        • Tanen M.
        • Hilliard D.
        • et al.
        Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1.
        Clin Pharmacol Ther. 2010; 88: 801-808
        • UK Prospective Diabetes Study (UKPDS) Group
        Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).
        Lancet. 1998; 352: 854-865
        • Kooy A.
        • de Jager J.
        • Lehert P.
        • Bets D.
        • Wulffele M.G.
        • Donker A.J.
        • et al.
        Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
        Arch Intern Med. 2009; 169: 616-625
        • de Jager J.
        • Kooy A.
        • Lehert P.
        • Wulffelé M.G.
        • van der Kolk J.
        • Bets D.
        • et al.
        Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.
        BMJ. 2010; 340: c2181
        • Sahin M.
        • Tutuncu N.B.
        • Ertugrul D.
        • Tanaci N.
        • Guvener N.D.
        Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus.
        J Diabetes Complicat. 2007; 21: 118-123
        • Welch G.N.
        • Loscalzo J.
        Homocysteine and atherothrombosis.
        N Engl J Med. 1998; 338: 1042-1050
        • Wile D.J.
        • Toth C.
        Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy.
        Diabetes Care. 2010; 33: 156-161
        • Berchtold P.
        • Bolli P.
        • Arbenz U.
        • Keiser G.
        Disturbance of intestinal absorption following metformin therapy (observations on the mode of action of biguanides) [Article in German].
        Diabetologia. 1969; 5: 405-412
        • Callaghan T.S.
        • Hadden D.R.
        • Tomkin G.H.
        Megaloblastic anaemia due to vitamin B12 malabsorption associated with long-term metformin treatment.
        Br Med J. 1980; 280: 1214-1215
        • Tomkin G.H.
        • Hadden D.R.
        • Weaver J.A.
        • Montgomery D.A.
        Vitamin-B12 status of patients on long-term metformin therapy.
        Br Med J. 1971; 2: 685-687
        • Adams J.F.
        • Clark J.S.
        • Ireland J.T.
        • Kesson C.M.
        • Watson W.S.
        Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy.
        Diabetologia. 1983; 24: 16-18
        • Bauman W.A.
        • Shaw S.
        • Jayatilleke E.
        • Spungen A.M.
        • Herbert V.
        Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin.
        Diabetes Care. 2000; 23: 1227-1231
        • Wulffele M.G.
        • Kooy A.
        • Lehert P.
        • Bets D.
        • Ogterop J.C.
        • Borger Van Der Burg B.
        • et al.
        Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
        J Intern Med. 2003; 254: 455-463
        • Hermann L.S.
        • Nilsson B.O.
        • Wettre S.
        Vitamin B12 status of patients treated with metformin: a cross-sectional cohort study.
        Br J Diabetes Vasc Dis. 2004; 4: 401-406
        • Ting R.Z.
        • Szeto C.C.
        • Chan M.H.
        • Ma K.K.
        • Chow K.M.
        Risk factors of vitamin B(12) deficiency in patients receiving metformin.
        Arch Intern Med. 2006; 166: 1975-1979
        • Pflipsen M.C.
        • Oh R.C.
        • Saguil A.
        • Seehusen D.A.
        • Seaquist D.
        • Topolski R.
        The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes: a cross-sectional study.
        J Am Board Fam Med. 2009; 22: 528-534
        • Nervo M.
        • Lubini A.
        • Raimundo F.V.
        • Faulhaber G.A.
        • Leite C.
        • Fischer L.M.
        • et al.
        Vitamin B12 in metformin-treated diabetic patients: a cross-sectional study in Brazil.
        Rev Assoc Med Bras. 2011; 57: 46-49
        • Reinstatler L.
        • Qi Y.P.
        • Williamson R.S.
        • Garn J.V.
        • Oakley Jr., G.P.
        Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: the National Health and Nutrition Examination Survey, 1999–2006.
        Diabetes Care. 2012; 35: 327-333
        • Gilligan M.A.
        Metformin and vitamin B12 deficiency.
        Arch Intern Med. 2002; 162: 484-485
        • Andrès E.
        • Noel E.
        • Goichot B.
        Metformin-associated vitamin B12 deficiency.
        Arch Intern Med. 2002; 162: 2251-2252
        • Filioussi K.
        • Bonovas S.
        • Katsaros T.
        Should we screen diabetic patients using biguanides for megaloblastic anaemia.
        Aust Fam Physician. 2003; 32: 383-384
        • Liu K.W.
        • Dai L.K.
        • Jean W.
        Metformin-related vitamin B12 deficiency.
        Age Ageing. 2006; 35: 200-201
        • Bell D.S.
        Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy.
        South Med J. 2010; 103: 265-267
        • DeFronzo R.A.
        • Goodman A.M.
        Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
        N Engl J Med. 1995; 333: 541-549
        • Hoffbrand V.
        • Provan D.
        ABC of clinical haematology. Macrocytic anaemias.
        BMJ. 1997; 314: 430-433
        • Snow C.F.
        Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician.
        Arch Intern Med. 1999; 159: 1289-1298
        • Qureshi S.
        • Ainsworth A.
        • Winocour P.
        Metformin therapy and assessment for vitamin B12 deficiency: is it necessary?.
        Pract Diabetes. 2011; 28: 302-304
        • Jensen R.T.
        Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
        Basic Clin Pharmacol Toxicol. 2006; 98: 4-19
        • Ruscin J.M.
        • Page 2nd, R.L.
        • Valuck R.J.
        Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.
        Ann Pharmacother. 2002; 36: 812-816
        • Bell D.S.
        Nondiabetic neuropathy in a patient with diabetes.
        Endocr Pract. 1995; 1: 393-394
        • Carmel R.
        How I treat cobalamin (vitamin B12) deficiency.
        Blood. 2008; 112: 2214-2221
        • Antony A.C.
        Megaloblastic anemias.
        in: Hoffman R. Benz E.J. Shattil S.J. Hematology: basic principles and practice. 4th ed. Churchill Livingstone, New York2005: 519
        • Matchar D.B.
        • McCrory D.C.
        • Millington D.S.
        • Feussner J.R.
        Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency.
        Am J Med Sci. 1994; 308: 276-283
        • Moore E.
        • Mander A.
        • Ames D.
        • Carne R.
        • Sanders K.
        • Watters D.
        Cognitive impairment and vitamin B12: a review.
        Int Psychogeriatr. 2012; 24: 541-556
        • Naurath H.J.
        • Joosten E.
        • Riezler R.
        • Stabler S.P.
        • Allen R.H.
        • Lindenbaum J.
        Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations.
        Lancet. 1995; 346: 85-89
        • Lindenbaum J.
        • Savage D.G.
        • Stabler S.P.
        • Allen R.H.
        Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations.
        Am J Hematol. 1990; 34: 99-107
        • Tefferi A.
        • Pruthi R.K.
        The biochemical basis of cobalamin deficiency.
        Mayo Clin Proc. 1994; 69: 181-186
      1. Rosenson RS, Kang DS. Overview of homocysteine. Available on 2012 UpToDate, Inc.

        • Savage D.G.
        • Lindenbaum J.
        • Stabler S.P.
        • Allen R.H.
        Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies.
        Am J Med. 1994; 96: 239-246
      2. Schrier SL. Diagnosis and treatment of vitamin B12 and folic acid deficiency. Available on 2012 UpToDate, Inc.

        • Hvas A.M.
        • Nexo E.
        Diagnosis and treatment of vitamin B12 deficiency. An update.
        Haematologica. 2006; 91: 1506-1512
        • Carmel R.
        Current concepts in cobalamin deficiency.
        Annu Rev Med. 2000; 51: 357-375
        • Andres E.
        • Serraj K.
        • Mecili M.
        • Kaltenbach G.
        • Vogel T.
        The syndrome of food-cobalamin malabsorption: a personal view in a perspective of clinical practice.
        J Blood Disord Transfus. 2011; 2: 108
        • Mazokopakis E.E.
        • Karefilakis C.M.
        • Giannopoulou C.
        Is Schilling test necessary for the etiological diagnosis of B12 insufficiency.
        Hell J Nucl Med. 2009; 12: 84-86
        • Andrès E.
        • Loukili N.H.
        • Noel E.
        • Kaltenbach G.
        • Abdelgheni M.B.
        • Perrin A.E.
        • et al.
        Vitamin B12 (cobalamin) deficiency in elderly patients.
        CMAJ. 2004; 171: 251-259
        • Oh R.
        • Brown D.L.
        Use of metformin is a cause of vitamin B12 deficiency.
        Am Fam Physician. 2004; 69 ([author reply 264, 266]): 264
        • Gargari B.P.
        • Aghamohammadi V.
        • Aliasgharzadeh A.
        Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes.
        Diabetes Res Clin Pract. 2011; 94: 33-38
        • Mohammadi M.
        • Amini M.
        • Aminiorroay A.
        • Rezvanian H.
        • Kachuei A.
        • Siyavash M.
        • et al.
        Effect of metformin and folic acid on plasma homocysteine level in type 2 diabetic patients.
        Int J Med Sci. 2009; 1: 88-90
        • Hultdin J.
        • Van Guelpen B.
        • Bergh A.
        • Hallmans G.
        • Stattin P.
        Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.
        Int J Cancer. 2005; 113: 819-824
        • Stevens V.L.
        • Rodriguez C.
        • Pavluck A.L.
        • McCullough M.L.
        • Thun M.J.
        • Calle E.E.
        Folate nutrition and prostate cancer incidence in a large cohort of US men.
        Am J Epidemiol. 2006; 163: 989-996
        • Buvat D.R.
        Use of metformin is a cause of vitamin B12 deficiency.
        Am Fam Physician. 2004; 69: 264
        • Stowers J.M.
        • Smith O.A.
        Vitamin B12 and metformin.
        Br Med J. 1971; 3: 246-247
        • Mahajan R.
        • Gupta K.
        Revisiting metformin: annual vitamin B12 supplementation may become mandatory with long-term metformin use.
        J Young Pharm. 2010; 2: 428-429